Literature DB >> 696422

Serum aminotransferases after low-dose heparin treatment. Short communication.

R Olsson, B M Korsan-Bengtsen, K Korsan-Bengtsen, J Lennartsson, J Waldenström.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 696422     DOI： 10.1111/j.0954-6820.1978.tb08428.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


× No keyword cloud information.
  5 in total

1.  Adverse effects of three different forms of heparin therapy: thrombocytopenia, increased transaminases, and hyperkalaemia.

Authors:  M Monreal; E Lafoz; R Salvador; J Roncales; A Navarro
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Enoxaparin-induced hepatotoxicity: an under-recognised complication of enoxaparin therapy.

Authors:  Katie Ann Pivarnik; Fred Schiffman; James Sullivan; Arkadiy Finn
Journal:  BMJ Case Rep       Date:  2016-09-23

3.  The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers.

Authors:  A H Harrill; J Roach; I Fier; J S Eaddy; C L Kurtz; D J Antoine; D M Spencer; T K Kishimoto; D S Pisetsky; B K Park; P B Watkins
Journal:  Clin Pharmacol Ther       Date:  2012-06-27       Impact factor: 6.875

4.  A randomized, placebo-controlled trial to determine the course of aminotransferase elevation during prolonged acetaminophen administration.

Authors:  Kennon Heard; Jody L Green; Victoria Anderson; Becki Bucher-Bartelson; Richard C Dart
Journal:  BMC Pharmacol Toxicol       Date:  2014-07-22       Impact factor: 2.483

Review 5.  Enoxaparin-Induced Liver Injury: Case Report and Review of the Literature and FDA Adverse Event Reporting System (FAERS).

Authors:  Katherine J Hahn; Shannon J Morales; James H Lewis
Journal:  Drug Saf Case Rep       Date:  2015-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.